- Contractors
- Melinta Therapeutics, LLC
Melinta Therapeutics, LLC
Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)
Melinta Therapeutics has 1 federal contract of $100,000 or more active since October 2023, with $47.5M obligated, from 1 agency. 1 is still running.
- Contracts
- 1 since FY2024$47,521,248 obligated, contracts of $100,000 or more
- Running now
- 1 contract
- Biggest customer
- Office of Assistant Secretary for Preparedness and Response$47.5M on 1 contract
- Main industry
- Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714
- UEI
- H8K6F2A4KD49Unique entity ID in SAM.gov
- Source
- USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC
Running contracts
Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.
| Contract | Obligated | Ends | State |
|---|---|---|---|
| Advance the Development of Two Antibiotics for Use in the Pediatric Population for the Treatment of Serious Bacterial Infections Where Multidrug-Resistant Organisms Are Common, and 2) Develop…Office of Assistant Secretary for Preparedness and Response · 75A50123C00022 | $47,521,248 | Jun 30, 2030in 43 months | DC |
End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.
Who they work for
| Agency | Amount | Share |
|---|---|---|
| Office of Assistant Secretary for Preparedness and Response1 contract | $47,521,248 |
What they sell
| Industry | Amount | Share |
|---|---|---|
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 · 1 contract | $47,521,248 |
Where the work is
| Place of work | Amount | Share |
|---|---|---|
| District of Columbia1 contract | $47,521,248 |
Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Office of Assistant Secretary for Preparedness and Response: see the list.
Get new notices like Melinta Therapeutics's work
New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.
Free. We use your email only for these alerts and never share it. Privacy